Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1952 1
1956 1
1958 1
1959 1
1960 1
1964 1
1965 1
1966 1
1967 2
1972 2
1976 2
1980 1
1985 1
1987 2
1988 1
1989 3
1990 1
1991 2
1992 3
1993 2
1994 2
1995 3
1996 1
1997 3
1998 4
1999 2
2000 5
2001 3
2002 4
2003 4
2004 1
2005 4
2006 1
2008 3
2009 3
2010 3
2012 3
2013 1
2014 4
2015 3
2016 2
2017 3
2020 5
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z. Stupp R, et al. Among authors: engelhard hh. JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669. JAMA. 2015. PMID: 26670971 Free article. Clinical Trial.
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. Stupp R, et al. Among authors: engelhard h. Eur J Cancer. 2012 Sep;48(14):2192-202. doi: 10.1016/j.ejca.2012.04.011. Epub 2012 May 18. Eur J Cancer. 2012. PMID: 22608262 Free article. Clinical Trial.
Intracranial ependymoma.
Maksoud YA, Hahn YS, Engelhard HH. Maksoud YA, et al. Among authors: engelhard hh. Neurosurg Focus. 2002 Sep 15;13(3):e4. doi: 10.3171/foc.2002.13.3.5. Neurosurg Focus. 2002. PMID: 15844876 Review.
Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues.
Naseri Kouzehgarani G, Feldsien T, Engelhard HH, Mirakhur KK, Phipps C, Nimmrich V, Clausznitzer D, Lefebvre DR. Naseri Kouzehgarani G, et al. Among authors: engelhard hh. Adv Drug Deliv Rev. 2021 Jun;173:20-59. doi: 10.1016/j.addr.2021.03.002. Epub 2021 Mar 9. Adv Drug Deliv Rev. 2021. PMID: 33705875 Free article. Review.
Commentary.
Engelhard HH. Engelhard HH. Surg Neurol. 2000 Nov;54(5):378-379. doi: 10.1016/s0090-3019(01)00334-2. Surg Neurol. 2000. PMID: 11342016 No abstract available.
Fibrinolytic therapy in intraventricular hemorrhage.
Andrews CO, Engelhard HH. Andrews CO, et al. Among authors: engelhard hh. Ann Pharmacother. 2001 Nov;35(11):1435-48. doi: 10.1345/aph.10383. Ann Pharmacother. 2001. PMID: 11724097 Review.
102 results